Post-treatment progression of tumors is commonly explained by somatic Darwinian evolution (i.e., selection of cells carrying genetic mutations that create more aggressive cell traits). But cancer genome and transcriptome analyses now paint a picture far more complex, prompting us to see beyond the Darwinian scheme: non-genetic cell phenotype plasticity explained by alternative stable gene expression states (\u27attractors\u27), may also produce aggressive phenotypes that can be selected for, without mutations. Worse, treatment may even induce cell state transitions into more malignant attractors. We review recent evidence for non-genetic mechanisms of progression, explain the theoretical foundation of attractor transitions behind treatment-...
The development of cancer begins with cells transitioning from their multicellular nature to a state...
Cancer mostly is a disease of old age. Evolutionary pressures have pushed the somatic "error rate", ...
Genetic and phenotypic heterogeneity contribute to the generation of diverse tumor cell populations,...
Post-treatment progression of tumors is commonly explained by somatic Darwinian evolution (i.e., sel...
International audienceAlthough neo-Darwinian (and less often Lamarckian) dynamics are regularly invo...
As well as undergoing genetic evolution, cancer cells can alter their epigenetic state to adapt and ...
Cancer cells acquire genotypic and phenotypic changes over the course of the disease. A minority of ...
By definition, a driver mutation confers a growth advantage to the cancer cell in which it occurs, w...
The development of drug resistance, the prime cause of failure in cancer therapy, is commonly explai...
Abstract The biology of cancer is critically reviewed and evidence adduced that its development can...
The role of plasticity and epigenetics in shaping cancer evolution and response to therapy has taken...
By definition, a driver mutation confers a growth advantage to the cancer cell in which it occurs, w...
Tumorigenesis in humans is thought to be a multistep process where certain mutations confer a select...
<div><p>Cells of different organs at different ages have an intrinsic set of kinetics that dictates ...
BACKGROUND: Genetic alterations of somatic cells can drive non-malignant clone formation and promote...
The development of cancer begins with cells transitioning from their multicellular nature to a state...
Cancer mostly is a disease of old age. Evolutionary pressures have pushed the somatic "error rate", ...
Genetic and phenotypic heterogeneity contribute to the generation of diverse tumor cell populations,...
Post-treatment progression of tumors is commonly explained by somatic Darwinian evolution (i.e., sel...
International audienceAlthough neo-Darwinian (and less often Lamarckian) dynamics are regularly invo...
As well as undergoing genetic evolution, cancer cells can alter their epigenetic state to adapt and ...
Cancer cells acquire genotypic and phenotypic changes over the course of the disease. A minority of ...
By definition, a driver mutation confers a growth advantage to the cancer cell in which it occurs, w...
The development of drug resistance, the prime cause of failure in cancer therapy, is commonly explai...
Abstract The biology of cancer is critically reviewed and evidence adduced that its development can...
The role of plasticity and epigenetics in shaping cancer evolution and response to therapy has taken...
By definition, a driver mutation confers a growth advantage to the cancer cell in which it occurs, w...
Tumorigenesis in humans is thought to be a multistep process where certain mutations confer a select...
<div><p>Cells of different organs at different ages have an intrinsic set of kinetics that dictates ...
BACKGROUND: Genetic alterations of somatic cells can drive non-malignant clone formation and promote...
The development of cancer begins with cells transitioning from their multicellular nature to a state...
Cancer mostly is a disease of old age. Evolutionary pressures have pushed the somatic "error rate", ...
Genetic and phenotypic heterogeneity contribute to the generation of diverse tumor cell populations,...